Inflection Biosciences logo

Inflection Biosciences


Inflection Biosciences Ltd is an early stage, drug development company with a focus on discovering and developing innovative small molecule therapeutics addressing major unmet needs in cancer.


Add photos to showcase Inflection Biosciences’s culture


Add Inflection Biosciences’s values

Insider experiences

Share your experience of working at Inflection Biosciences

Darren Cunningham
CEO and Co-Founder
Shaun McNulty
Chief Scientific Officer
Tess Barker
Head of Development
Kathy Gately
Senior Scientist (Translational Oncology)
Paul Dickinson
CMC: Preclinical and Clinical Formulation Development
David Lathbury
CMC: Process Chemistry
Frank Bonner
Head of Non-Clinical Safety
Gerry McGettigan
Regulatory Affairs
Gemma Carroll
Financial Controller

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure